EUVIMED · CrossrefZeitschrift
European Urology Focus
ISSN 2405-4569 · Elsevier BV
Neueste Artikel
One-year Outcomes of Female Artificial Urinary Sphincter Implantation in Europe: The VENUS Registry
Germ line Mutation Incidence in Patients with Prostate Cancer and Additional Cancers
Re: Marie Semmler, Julian Marcon, Elena K. Berg, et al. Radical Prostatectomy Without Prior Biopsy? Final Histopathology of Radical Prostatectomies in 103 Consecutive Biopsy-naive Patients Who Underwent Radical Prostatectomy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.06.030
Quality-of-life Outcomes and Patient-reported Outcome Measures After Penile-preserving Surgery to Treat Penile Cancer: A Systematic Review and Meta-analysis
Clinical Outcomes and Malignant Potential of Urothelial Atypia Without Previous Bladder Cancer
What Pediatric and Adult Urologists Should Know About Genetics in CAKUT
Re: Thomas Dreyer, Simone Brandt, Fabrin Knud, et al. Use of the Xpert Bladder Cancer Monitor for Guiding Cystoscopy in High-grade Non–muscle-invasive Bladder Cancer: Results from the Randomized Controlled DaBlaCa-15 Trial. Eur Urol 2025;88:23–30
Re: Cameron E. Alexander, Hannah Warren, Alexander Light, et al. Ultrasound for the Diagnosis of Testicular Torsion: A Systematic Review and Meta-analysis of Diagnostic Accuracy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.04.026
Re: Evan Suzman, B. Malik Wahba, Gal Wald, Aayush Kaneria, Jim C. Hu. Review of Transperineal and Transrectal Prostate Biopsy Outcomes. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.07.017
Re: Tamás Fazekas, Marcin Miszczyk, Alexander Giesen, et al. Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life—A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.006
Re: Quynh Chi Le, Andrea Marmiroli, Mattia Longoni, et al. Life Expectancy of Renal Cell Carcinoma with Variant Histology. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2025.05.023
Re: Siamak Daneshmand, Michiel S. Van der Heijden, Joseph M. Jacob, et al. TAR-200 for Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: Results from the Phase IIb SunRISe-1 Study. J Clin Oncol. In press. https://doi.org/10.1200/jco-25-01651
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?
Identification of Biomarkers Predictive of Successful Salvage Surgery in Prostate-specific Membrane Antigen Positron Emission Tomography–positive Oligorecurrent Prostate Cancer: Results from the BioPoP Trial
Long-term Functional Outcomes and Decision Regret after Robot-assisted Radical Prostatectomy: An Experienced Surgeon Series
Holmium Laser Enucleation of the Prostate in Octogenarians: 16-year Experience in a High-volume Center
Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysis
Tissue Penetration of Gemcitabine and Gemcitabine Phosphate Metabolites Following Gemcitabine Intravesical System Administration Versus Standard Intravesical Instillation in a Preclinical Minipig Model
EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused Sampling
PI-RADS–stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy
Paclitaxel Drug-coated Balloon (Optilume) for Ureteral Stricture Management: Technical Description and Initial Clinical Experience
NCCN Guideline Updates on Radiopharmaceutical Therapy for Prostate Cancer
Radioligand Therapy Hormone Combinations and the ENZA-p Trial
Early-access Use of Radioligand Therapy in Prostate Cancer
Radioligand Therapy (RLT) in France
How Will PSMAddition Impact the Management of Prostate Cancer?
New Paradigms in Theranostics of Prostate Cancer: The Rise of α-Emitters and Next-generation Targets
Success and Limitations of PSMA RLT : The Nuclear Medicine View
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial
EUVIMED